Rare-disease foundation backs regenerative research
CureDuchenne is investing in and collaborating with Mesentech, a company with a prodrug platform designed to selectively deliver therapeutics to bone.
Archives for December 3, 2020
Medable lands $91m to fuel decentralized trial tech
The Series C funding will be used to help accelerate the research industry’s adoption of decentralized and digital clinical trial technology.
Latest FDA COVID-19 news
As the pandemic continues to impact the globe, the agency has kept busy issuing EUAs for potential treatments, and cited sellers of unapproved treatments.